Phase III study of AJG511 in patients with active ulcerative colitis
Phase of Trial: Phase III
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Budesonide (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors EA Pharma
- 28 Oct 2016 Status changed from active, no longer recruiting to completed.
- 22 Jun 2016 Status changed from completed to active, no longer recruiting.
- 20 Jun 2016 Status changed from active, no longer recruiting to completed.